Dual Kinase Inhibition in the Treatment of Breast Cancer: Initial Experience with the EGFR/ErbB-2 Inhibitor Lapatinib
Year: 2004
Type: article
Source: The Oncologist
Author: Howard A. Burris
Institutions: Sarah Cannon, Tennessee Oncology
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: GlaxoSmithKline
OpenAlex ID: W2115007832